Can an Effective SARS-CoV-2 Vaccine Be Developed for the Older Population?

Immunity and Ageing - United Kingdom
doi 10.1186/s12979-020-00180-2
Full Text
Abstract

Available in full text

Categories
AgingImmunology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The SARS-CoV-2 Vaccine Pipeline: An Overview

Current Tropical Medicine Reports
Infectious DiseasesAllergyImmunology
2020English

Rhesus Macaques Can Be Effectively Infected With SARS-CoV-2 via Ocular Conjunctival Route

2020English

Early Spread of SARS-Cov-2 in the Icelandic Population

2020English

Multi-Epitope Vaccine Design Using an Immunoinformatics Approach for 2019 Novel Coronavirus in China (SARS-CoV-2)

2020English

Can Zinc Correction in SARS-CoV-2 Patients Improve Treatment Outcomes?

2020English

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity

2020English

The Global Population of SARS-CoV-2 Is Composed of Six Major Subtypes

2020English

The Wuhan SARS-CoV-2 - What's Next for China

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy